Welcome to www.pliva.com

PLIVA OPENS NEW STATE-OF-THE-ART AZITHROMYCIN PRODUCTION FACILITY

PLIVA, the largest pharmaceutical company in Central and Eastern Europe, announces that its new Azithromycin production plant has been completed. The project worth US$ 100 million is PLIVA’s biggest investment in a production site to date. A major part of the investment has been financed by PLIVA’s own funds.

Zagreb, 4th September 1998

© 2017 PLIVA HRVATSKA d.o.o. / All rights reserved. / Legal information / Impressum